Magnesium L-Threonate and Cognition: What the Human Trials Show

Magnesium L-threonate is the magnesium salt of L-threonic acid, a vitamin C metabolite. The compound was developed in Guosong Liu's lab at MIT and licensed as Magtein for the explicit purpose of raising magnesium concentrations in the brain. In rodents, the formulation produced changes in synaptic density and learning that other magnesium salts did not. The marketing has since outrun the human evidence — but the human evidence is finally arriving.

What the chemistry actually claims

All oral magnesium salts raise serum magnesium roughly equivalently when matched for elemental dose. The threonate formulation's distinguishing claim is increased cerebrospinal fluid (CSF) magnesium, mediated by threonate-facilitated transport across the blood–brain barrier and modulation of magnesium-specific transporters. The original 2010 Neuron paper from Liu's group showed CSF magnesium rose roughly 15% in rats receiving threonate but not in those receiving equivalent elemental doses of magnesium chloride or magnesium citrate [1].

The pivotal human RCT

The first head-on human cognition trial appeared in 2016: 51 adults aged 50–70 with subjective memory complaints randomised to 1.5–2 g/day of magnesium threonate (providing ~150 mg elemental magnesium) or placebo for 12 weeks. The threonate arm showed improvements on a composite executive function score, working memory, and a "brain age" assay calculated from neuropsychological battery performance [2]. Effect sizes were moderate (Cohen's d ≈ 0.3–0.5), and the trial was funded by the supplement manufacturer.

The 2024 anxiety and sleep trial

A 2024 randomised trial in 80 adults with subclinical anxiety tested 2 g/day of magnesium L-threonate for 4 weeks. Scores on the Hamilton Anxiety Rating Scale improved more in the threonate arm than placebo, and self-reported sleep efficiency rose modestly [3]. The trial was small, single-centre, and again industry-funded, but the direction matched the underlying neurobiology.

What the comparator literature shows

Pure magnesium (any form) has a small but real effect on subjective sleep quality and on anxiety in adults with low dietary intake [4]. A 2017 meta-analysis of magnesium for migraine and depression concluded effects were similar across magnesium oxide, citrate, glycinate, and threonate when matched for elemental dose [5]. In other words, much of what threonate appears to do in human trials may simply reflect correcting subclinical magnesium deficiency — something cheaper salts also accomplish.

Cost and elemental dose realities

Magnesium L-threonate is roughly 8% elemental magnesium by weight. A typical 2 g dose delivers ~160 mg elemental — slightly under the 320–420 mg RDA. The same elemental load from magnesium glycinate or citrate costs less per month. The threonate-specific argument therefore depends on whether the brain-targeted pharmacokinetics produce effects above and beyond plain magnesium correction, and the human evidence is suggestive but not conclusive.

Safety and interactions

Magnesium L-threonate is well tolerated. Diarrhoea is less common than with oxide or citrate because of the lower elemental dose. People with chronic kidney disease should not take any magnesium supplement without nephrology input. Threonate does not appear to interact meaningfully with most medications, though it can reduce absorption of fluoroquinolones, tetracyclines, and bisphosphonates if co-administered — the same magnesium-specific cation effect that applies to all magnesium salts [6].

Practical takeaway

Magnesium L-threonate has the most plausible mechanistic story among magnesium supplements for cognition and the only two RCTs specifically powered for cognitive endpoints. The trials are small, industry-funded, and have not been replicated independently. If correcting magnesium deficiency is the goal, magnesium glycinate at 200–300 mg elemental is cheaper and equally well tolerated. If the goal is brain-specific magnesium repletion in a healthy adult, threonate is the only formulation with any directly relevant human data — but the certainty does not yet justify the price tag.